Return to List

Study Summary
No. 2009-0412:.......Pancreas......Jason B. Fleming......Surgical Oncology
.
Study Summary Title
Study Summary
Number:		2009-0412
Study Title:Correlative Study of Nutrition and Quality of Life in Patients with Pancreatic Cancer
.
Physician New Patient Referral
Name:Jason B. FlemingPatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Surgical OncologyReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-745-0890
Contact us about clinical trials
.
General Information
Disease Group:PancreasSupported By:Pancreatic Research Fund 80010941
Phase of Study:N/AReturn
Visit:		No return visits required for this protocol
Treatment
Agents:		NoneHome Care:N/A
Treatment Loc:Only at MDACC
Estimated
Length of Stay
in Houston:		no hospitalization associated with this protocol
Description/
Intervention:		The goal of this research study is to learn about the quality-of-life and
nutritional health of patients with a mass in or near the pancreas. Researchers
also want to learn the effectiveness of current instruments that are used to
measure quality-of-life and nutritional health and if certain quality-of-life
issues can be used to predict a patient's stage of disease or their chances of
having surgery.
.
Study Objectives / Outcomes
1. Primary Objective- To correlate nutritional assessments (as measured by PG-SGA [Patient-Generated Subjective Global Assessment]) with quality of life measurements as quantified using FACT-Hep (Functional Assessment of Cancer Therapy-Hepatobiliary Questionnaire) in patients with pancreatic cancer.

2. Secondary Objectives - (a) To correlate scores on PG-SGA or FACT-Hep with cancer stage using the American Joint Commission on Cancer (AJCC) system. (b) Determine if individual patient PG-SGA or FACT-Hep scores correlate with completion of preoperative therapy and surgical resection.
.
Study Status Information
Study Activation / Registration Date:
IRB Review and Approval Date:07/16/2009
Study Type:Behavioral
Recruitment Status:Open
Projected Accrual:N/A
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:1) All patients undergoing surgical evaluation and/or treatment for suspected or proven localized pancreatic cancer at MDACC

2) Eighteen years of age or older

3) Physically capable of completing the necessary questionnaires.
Exclusion Criteria:1) Non-English speaking patients

2) Patients who have undergone prior anti-neoplastic treatment for pancreatic/periampullary neoplasm(s).

3) Patients physically incapable of completing the necessary questionnaires. (Incapacity includes but is not limited to individuals having a significant history or diagnosis of mental health disorder.)
.
Links
Registration Number: Not Applicable Clinical Trial
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center